黃耀斌 教授兼總務長
Professor Yaw-Bin Huang

電話:07-3121101 ext 2166 or 2123
E-mail:yabihu@kmu.edu.tw

 

學歷

  • 高雄醫學院 藥學研究所藥學博士 (1988/09-1996/01)
  • 高雄醫學院 藥學研究所藥學碩士 (1984/09-1986/06)
  • 高雄醫學院 藥學系藥學士 (1980/09-1984/06)

現任本職:

  • 高雄醫學大學 藥學院 院長 (2018/02/01~迄今)
  • 高雄醫學大學 總務長 (2015/08/01~迄今)
  • 高雄醫學大學藥學系 教授 (2005/08/01~迄今)
  • 台灣藥學會 理事長 (2019/03/31~迄今)
  • 高雄醫學大學附設中和紀念醫院藥劑部 總級藥師 (2008/08/01~迄今)

經歷

  • 高雄醫學大學附設中和紀念醫院藥劑部主任 (2008/08-2015/07)
  • 高雄醫學大學藥學系 臨床藥學碩士班班主任 (2013/08-2018/07)
  • 高雄醫學大學臨床藥學研究所所長 (2005/11-2013/07)
  • 高雄醫學大學臨床藥學研究所教授 (2006/08-2013/07)
  • 高雄醫學大學藥學系教授 (2005/02-2006/07)
  • 高雄醫學大學藥學系副教授 (1995/08-2005/01)
  • 高雄醫學院藥學系講師 (1986/08-1995/07)
  • 高雄醫學大學教務處教學發展組組長 (2014/08-2015/07)
  • 高雄醫學大學教師發展及教學資源中心組長 (2009/08-2012/07)
  • 高雄醫學大學教務處研教組組長 (2007/08-2009/07)
  • 高雄醫學大學進修推廣部主任 (2003/08-2005/11)
  • 高雄醫學大學視聽中心主任 (2003/08-2005/11)
  • 高雄醫學院附設中和紀念醫院藥劑科臨床藥學組組長 (1996/08-1999/07)
  • 考選部命題審題委員及典試委員

學術專長

  • 生物藥劑學/藥物動力學/藥劑學/臨床藥學

 


研究成果期刊論文(2012-2015):

  1. Yi-Hung Tsai, Jung-Tzu Chang, Chi-Te Huang, Jui-Sheng Chang, Yaw-Bin Huang, Pao-Chu Wu*, 2012. Electrically-Assisted Skin Delivery of Buspirone Submicron Emulsions. J. Food Drug Anal. 20:22-26.
  2. Ming-Jun Tsai, Pao-Chu Wu, Yaw-Bin Huang, Jui-Sheng Chang, Chin-Lin Lin, Yi-Hung Tsai*, Jia-You Fang*, 2012. Baicalein loaded in tocol nanostructured lipid carriers (tocol NLCs) for enhanced stability and brain targeting. Int. J. Pharm. 423:461-470.
  3. Chen-Chun Kuo, Ying-Hao Lu*, Chi-Yu Chen, Yaw-Bin Huang, 2012. Study of Medication Safety in Consistency between Disease Diagnosis and Pharmacological Therapy: An Example of Oral Hypoglycemic Agents. Formosa Journal of Clinical Pharmacy 20: 11-24.
  4. Pei-Tzu Wang, Yaw-Bin Huang, Ming-Yen Lin, Pei-Fen Chuang, Shang-Jyh Hwang*, 2012. Prescriptions for angiotensin-converting enzyme inhibitors/angiotensin receptor blockers and monitoring of serum creatinine and potassium in patients with chronic kidney disease. Kaohsiung J. Med. Sci. 28:477-483.
  5. Yi-Ping Fang, Pao-Chu Wu, Yaw-Bin Huang; Cherng-Chyi Tzeng, Yeh-Long Chen, Yu-Han Hong, Ming-Jun Tsai*, Yi-Hung Tsai*, 2012. Grafting polyethylene glycol onto solid lipid nanoparticles encapsulating a novel chemotherapeutic agent (PK-L4) to enhance solubility for injection delivery. Int. J. Nanomed. 7:4995-5005.
  6. Yun Chao, Chi-Te Huang, Li-Tse Fu, Yaw-Bin Huang, Yi-Hung Tsai, Pao-Chu Wu*, 2012. The effect of submicron emulsion systems on transdermal delivery of kaempferol. Chem. Pharm. Bull. 60:1171-1175.
  7. Ming-Wei Lin, An-Shen Lin, Deng-Chyang Wu, Sophie S.W, Fang-Rong Chang, Yang-Chang Wu, Yaw-Bin Huang*, 2012. Euphol from Euphorbia tirucalli selectively inhibits human gastric cancer cell growth through the induction of ERK1/2-mediated apoptosis. Food Chem. Toxicol. 50:4333-4339.
  8. Chung-Yu Chen, Kun-Tai Lee, Charles Tzu-Chi Lee, Wen-Ter Lai and Yaw-Bin Huang*, 2012. Effectiveness and safety of antiplatelet therapy in stroke recurrence prevention in patients with liver cirrhosis: a 2-year follow-up study. Pharmacoepidem. Dr. S. 21:1334-1343.
  9. Chung-Yu Chen, Kun-Tai Lee, Charles Tzu-Chi Lee, Wen-Ter Lai, and Yaw-Bin Huang*, 2013. Epidemiology and Clinical Characteristics of Congenital Hypothyroidism in an Asian Population:A Nationwide Population-Based Study. J. Epidemiol. 23:85-94.
  10. Chung-Yu Chen, Kun-Tai Lee, Charles Tzu-Chi Lee, Wen-Ter Lai, Yaw-Bin Huang*, 2013. Epidemiology and disease burden of ulcerative colitis in Taiwan: A nationwide population-based study. Value in Health Regional 2:127-134.
  11. Chung-Yu Chen, Jiann-Woei Huang, Charles Tzu-Chi Lee, Wen-Ter Lai, Yaw-Bin Huang*, 2013. Long Term Ouctome of Patients With Aortic Aneurysms Taking Low-Dose Aspirin: A Population-Based Cohort Study. J. Invest. Med. 61:1004-1012.
  12. Chung-Yu Chen, Yaw-Bin Huang, Charles Tzu-Chi Lee*, 2013. Epidemiology and disease burden of ischemic stroke in Taiwan. Int. J. Neurosci. In press
  13. Chi-Te Huang, Ming-Jun Tsai,Yu-Hsuan Lin, Yaw-Sya Fu, Yaw-Bin Huang, Yi-Hung Tsai, Pao-Chu Wu*. 2013. Effect of microemulsions on transdermal delivery of citalopram: optimization studies using mixture design and response surface methodology. Int. J. Nanomed. 8: 2295-2304
  14. Yaw-Bin Huang, Chi-Te Huang, Hsin-Yeh Tsou, Li-Tse Fu, Yaw-Sya Fu, Yi-Hung Tsai, Pao-Chu Wu*. 2013. The transport effect of submicron emulsions on 5-flurouracil topical application. J. Microencapsul. 30: 425-431.
  15. Pi-Ju Tsai, Chi-Te Huang, Chen-Chou Lee, Chi-Lin Li, Yaw-Bin Huang, Yi-Hung Tsai, Pao-Chu Wu*, 2013. Isotretinoin oil-based capsule formulation optimization. The Scientific World Journal, 2013: 856967, 6 pages.
  16. Yaw-Bin Huang, Ming-Wei Lin, Yun Chao, Chi-Te Huang, Yi-Hung Tsai, Pao-Chu Wu*. 2014. Anti-oxidant activity and attenuation of bladder hyperactivity by the flavonoid compound kaempferol. Int. J. Urol. 21: 94-98.
  17. Li-Chia Chen, Teng-Chou Chen, Yaw-Bin Huang, Chao-Sung Chang, 2014. Disease acceptance and adherence to imatinib in Taiwanese chronic myeloid leukaemia outpatients. Int J Clin Pharm, 36: 120-7.
  18. Teng-Chou Chen, Li-Chia Chen, Yaw-Bin Huang, Chao-Sung Chang, 2014. Imatinib adherence associated clinical outcomes of chronic myeloid leukaemia treatment in Taiwan. Int J Clin Pharm, 36: 172-81.
  19. Pao-Chu Wu, Pi-Ju Tsai, Shin-Chen Lin, Yaw-Bin Huang*, 2014. Formulation optimization of arecoline patches. The Scientific World Journal, 2014: 945168, 7 pages.
  20. Chung-Yu Chen, Kun-Tai Lee, Charles Tzu-Chi Lee, Wen-Ter Lai*, and Yaw-Bin Huang*, 2014. Effectiveness and safety of antiplatelet in stroke patients with ESRD undergoing dialysis. Int J Stroke, 9: 580-590.
  21. Ming-Jun Tsai, Yaw-Syan Fu, Yu-Hsuan Lin, Yaw-Bin Huang, Pao-Chu Wu* , 2014. The Effect of Microemulsion as a Carrier of Hydrophilic Compound for Transdermal Delivery. PLoS One, 9:e102850.
  22. Hsu WH, Kuo CH, Wang SS, Lu CY, Liu CJ, Chuah SK, Kuo FC, Chen YH, Huang YB, Hou MF, Wu DC, Hu HM* , 2014. Acid suppressive agents and risk of Mycobacterium Tuberculosis: case–control study. BMC Gastroenterol, 14:91(1-7).
  23. Liu CJ, Kuo FC, Hu HM, Chen CY, Huang YB, Cheng KH, Yokoyama KK, Wu DC, Hsieh S, Kuo CH*, 2014. 17β-Estradiol inhibition of IL-6-Src and Cas and paxillin pathway suppresses human mesenchymal stem cells-mediated gastric cancer cell motility. Transl Res, 164:232-243.
  24. Chung-Yu Chen, Yaw-Bin Huang*, 2014. Bisphosphonates and Risk of Atrial Fibrillation. J Taiwan Pharm, 30:148-152.
  25. Wu CY, Lin MW, Wu DC, Huang YB, Huang HT, Chen CL*, 2014. The role of phosphoinositide-regulated actin reorganization in chemotaxis and cell migration. Brit J Pharmacol, 171:5541-5554.
  26. Ming-Jun Tsai, Yaw-Bin Huang, Jhih-Wun Fang, Yaw-Syan Fu, Pao-Chu Wu*, 2015. Preparation and evaluation of nano-carriers for naringenin topical application. Int J Pharm, 481:84-90.
  27. Yi-Cheng Chen , Pi-Ju Tsai, Yaw-Bin Huang, Pao-Chu Wu*, 2015. Optimization and validation of high-performance chromatographic condition for simultaneous determination of adapalene and benzoyl peroxide by response surface methodology. PLoS One, 10:0120171.
  28. Chin-Wei Hsu, Yaw-Bin Huang*, Chung-Yu Chen*, 2015. Effect of antithrombotic and antiplatelet agents for ischemic stroke in atrial fibrillation patients with dialysis. Int J Cardiol, 190:349.